These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19297124)

  • 1. [Resistant hypertension: evaluation and treatment].
    Girerd X; Rosenbaum D; Villeneuve F
    Presse Med; 2009 Apr; 38(4):643-51. PubMed ID: 19297124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
    Calhoun DA; Jones D; Textor S; Goff DC; Murphy TP; Toto RD; White A; Cushman WC; White W; Sica D; Ferdinand K; Giles TD; Falkner B; Carey RM
    Hypertension; 2008 Jun; 51(6):1403-19. PubMed ID: 18391085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and treatment of resistant hypertension.
    Pimenta E; Gaddam KK; Oparil S
    J Clin Hypertens (Greenwich); 2008 Mar; 10(3):239-44. PubMed ID: 18326968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on diagnosis and treatment of resistant hypertension.
    Pimenta E
    Iran J Kidney Dis; 2011 Jul; 5(4):215-27. PubMed ID: 21725176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines.
    Grassi G; Calhoun DA; Mancia G; Carey RM
    Curr Hypertens Rep; 2019 Jul; 21(9):67. PubMed ID: 31321564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant hypertension and aldosteronism.
    Pimenta E; Calhoun DA
    Curr Hypertens Rep; 2007 Nov; 9(5):353-9. PubMed ID: 18177580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.
    Acelajado MC; Calhoun DA
    Cardiol Clin; 2010 Nov; 28(4):639-54. PubMed ID: 20937447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
    Calhoun DA; Jones D; Textor S; Goff DC; Murphy TP; Toto RD; White A; Cushman WC; White W; Sica D; Ferdinand K; Giles TD; Falkner B; Carey RM;
    Circulation; 2008 Jun; 117(25):e510-26. PubMed ID: 18574054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension].
    Waeber B; Feihl F
    Rev Med Suisse; 2012 Jan; 8(323):28-30. PubMed ID: 22303736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology].
    Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
    Presse Med; 2014 Dec; 43(12 Pt 1):1325-31. PubMed ID: 25459067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistant hypertension].
    Feldstein CA
    Rev Med Chil; 2008 Apr; 136(4):528-38. PubMed ID: 18769797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology.
    Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
    J Hum Hypertens; 2016 Nov; 30(11):657-663. PubMed ID: 26818804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant Hypertension.
    Doroszko A; Janus A; Szahidewicz-Krupska E; Mazur G; Derkacz A
    Adv Clin Exp Med; 2016; 25(1):173-83. PubMed ID: 26935512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spironolactone in resistant essential hypertension].
    Lorthioir A; Belmihoub I; Fouassier D; Azizi M; Amar L
    Presse Med; 2019 Dec; 48(12):1431-1438. PubMed ID: 31473027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Resistant and Refractory Hypertension.
    Acelajado MC; Hughes ZH; Oparil S; Calhoun DA
    Circ Res; 2019 Mar; 124(7):1061-1070. PubMed ID: 30920924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management of the patient with difficult-to-control or resistant hypertension.
    Viera AJ; Hinderliter AL
    Am Fam Physician; 2009 May; 79(10):863-9. PubMed ID: 19496385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistant hypertension in office practice: a clinical approach.
    Siyam F; Brietzke SA; Sowers JR
    Hosp Pract (1995); 2010 Nov; 38(4):90-7. PubMed ID: 21068532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.